drugset / Trial / NCT05716256

Effect of Ulinastatin on the Action of NDMRs (Rocuronium / Cisatracurium)

NCT05716256

RandomizedParallel-groupTriple-blindOther

Summary

The aim of this research was to determine the influence of ulinastatin on nondepolarising muscle relaxants Rocuronium and Cisatracurium.

Timeline

Start
2023-02-15
Primary completion
2023-06-15
Completion
2023-06-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Ulinastatin Protein / enzyme biologic 5000 iu/kg

Indications

No indication recorded.